Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Fury Announces 2025 Exploration Plans at Committee Bay
-
Conavi Medical Announces New Grant of Stock Options
-
Guardian Capital LP Launches New GuardBonds™ Funds
-
A New Era for the Canada-U.S. Relationship
-
Matador Technologies Inc. Announces Listing on the Frankfurt Stock Exchange
-
Proven Hits Return to Citytv & Citytv+; The Price is Right Tonight with Host Howie Mandel, Coming Spring 2026
-
Flock Safety and Homegrown Launch the “Thriving Cities Fund” to Empower Local Entrepreneurs and Foster Safer, More Prosperous Communities
-
VEON and Engro Corporation Complete Pioneering Infrastructure Partnership in Pakistan
-
BioStem Technologies Provides Update on the Company’s Form 10 Submission and SEC Review Process
-
Halcones Precious Metals Provides Update on Polaris Gold Project, Antofagasta Region Chile
-
Next Hydrogen announces transition of its COO to a consulting arrangement
-
BeyondSpring Presents Efficacy/Safety Data from a Phase 2 Study of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on First-Line Immune Checkpoint Inhibitors at 2025 ASCO
-
Sultran Ltd. Celebrates 50 Years of Industry Leadership and Innovation
-
Greenbacker delivers first quarter results
-
Bio-Path Holdings Provides Clinical and Operational Update
-
Xtract One Announces Updates on One Gateway Launch
-
New Analysis of Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Published in Muscle and Nerve
-
I-Mab to Participate in the H.C. Wainwright “HCW@Home” Series
-
ValOre Highlights Strategic Synergies and Near-Term Exploration Plans for the Combined Pedra Branca Gold and PGM Projects, Ceara State, Brazil
-
QuantaSing to Report Third Fiscal Quarter Financial Results on June 6, 2025
-
Swvl Signs Its First SaaS Contract in the UK, Marking Entry into the European Market
-
Brookfield Announces Reset Dividend Rate on Its Series 42 Preference Shares
-
Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib
-
Beam Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to BEAM-101 for the Treatment of Sickle Cell Disease
-
FactSet Announces CEO Succession Plan
-
Monopar Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® Indexes
-
Chicago Atlantic BDC, Inc. Announces 2025 Annual Meeting of Stockholders’ Date
-
NIRI Twin Cities Chapter Elects 2025-2026 Board of Directors
-
Entrada Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors
-
Akero Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
-
Transpire Bio Enters into Exclusive License Agreement with Suzhou Intragrand Pharma for Investigational PDE4 Inhibitor
-
Sionna Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
-
OXB Highlights the Launch of its Innovation and Technology Excellence Board
-
VEON and Engro Corporation Complete Pioneering Infrastructure Partnership in Pakistan
-
Verkkokauppa.com Oyj - Managers' Transactions – Samuli Seppälä
-
Bitget Launches Second Year of Anti-Scam Month Campaign to Fight Growing Cyber Fraud
-
AMG Names Thomas M. Wojcik as President and Chief Operating Officer
-
Coloplast A/S - Invitation to Coloplast's Capital Markets Day on 2 September 2025
-
Bitget Wallet Launches Testnet Faucet Center to Simplify Testnet Token Access
-
Telix Investor Day in New York City on June 11, 2025: Presenting KOLs
-
Form 8.3 - [Alpha Group International PLC]
-
YieldMax® ETFs Announces Distributions on BIGY, RNTY and SOXY
-
Ashley Madison, Leading Hookup Site and Casual Dating Platform, Launches New ‘Discreet View Mode’ for Privacy
-
Endeavour Silver Continues to Confirm High-Grade Structures During its 2024/2025 Drill Program at Pitarrilla
-
Form 8.5 (EPT/RI) - Thruvision Group plc
-
RESOLUTIONS OF AFARAK GROUP SE’S ANNUAL GENERAL MEETING
-
Form 8.5 (EPT/RI) - FD Technologies plc
-
Form 8.5 (EPT/RI) - Dowlais Group plc
-
Form 8.5 (EPT/RI) - Craneware plc
-
Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., to Acquire Sitio Royalties Corp. in All-Equity Transaction; Increases Base Dividend
